LXRX - Lexicon Pharmaceuticals GAAP EPS of -$0.22 revenue of $0.32M
2023-08-03 16:09:08 ET
- Lexicon Pharmaceuticals press release ( NASDAQ: LXRX ): Q2 GAAP EPS of -$0.22.
- Revenue of $0.32M.
- As of June 30, 2023, Lexicon had $256.7 million in cash and investments, as compared to $138.4 million as of December 31, 2022.
For further details see:
Lexicon Pharmaceuticals GAAP EPS of -$0.22, revenue of $0.32M